Caricamento azienda
Just reported
Q3 2026 results
From National Healthcare's results release of 6 novembre 2026; its quarterly report has since been filed.
Revenue
Actual
408M USD
+6,6% y/y
0,0% q/qGuided
—
No guide given
EPS, GAAP
Actual
0,85 USD
-66% y/y
-67% q/qGuided
—
No guide given
EPS, adjusted: 1,76 USD
Operating income, GAAP
Actual
40,6M USD
+34% y/y
-17% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes National Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.22,8B USDA+
EHCEncompass Health Corporation13,8B USDA+
ENSGEnsign Group, Inc.11B USDA
PACSPACS Group, Inc.7,7B USDA
CONConcentra Group Holdings Parent, Inc.5,4B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 ott 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 ott 2026CAGraded C, now A
Costruito dai documenti depositati da National Healthcare Corp. presso la Securities and Exchange Commission (SEC), l’autorità di vigilanza statunitense. Le cifre sono quelle dichiarate, con lo storico per azione ricalcolato sulla base azionaria di oggi. Questo descrive un’azienda: non è consulenza finanziaria né una raccomandazione di acquisto o vendita.
